Cost analysis of breast cancer: a comparison between private and public hospitals in Iran. 2021

Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
Social Determinants of Health Research Center, School of Health, Guilan University of Medical Sciences, Rasht, Iran.

BACKGROUND Breast cancer is the most prevalent cancer among women. Breast cancer imposes a considerable economic burden on the health system. This study aimed to compare the cost of breast cancer among patients who referred to private and public hospitals in Iran (2017). METHODS This was a prevalence-based cost of illness study. A total of 179 patients were selected from private and public hospitals using the census method. The researcher-constructed checklist was used for data collection. Data were analyzed using SPSS software version 22. RESULTS The estimated total mean (SD) direct cost of patients who referred to the private hospital and the public hospital was $10,050 (19,480) and $3960 (6780), respectively. Further, the total mean indirect cost of patients who referred to the private hospital was lower than those referring to the public hospital at $1870 (15 % of total costs) and $22,350 (85 % of total costs), respectively. These differences were statistically significant (P < 0.05). CONCLUSIONS Breast cancer imposes a substantial cost on patients, health insurance organizations and the whole society in Iran. Therefore, the adoption of effective measures for the prevention and early diagnosis of breast cancer is urgently needed.

UI MeSH Term Description Entries
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006779 Hospitals, Public Hospitals controlled by various types of government, i.e., city, county, district, state or federal. Public Hospitals,Hospital, Public,Public Hospital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017048 Health Care Costs The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost. Medical Care Costs,Treatment Costs,Costs, Medical Care,Health Costs,Healthcare Costs,Cost, Health,Cost, Health Care,Cost, Healthcare,Cost, Medical Care,Cost, Treatment,Costs, Health,Costs, Health Care,Costs, Healthcare,Costs, Treatment,Health Care Cost,Health Cost,Healthcare Cost,Medical Care Cost,Treatment Cost
D017281 Cost of Illness The personal cost of disease which may be economic, social, or psychological. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, or QUALITY OF LIFE. It differs from HEALTH CARE COSTS, the societal cost of providing services related to the delivery of health care. Burden Of Disease,Burden of Illness,Disease Burden,Disease Costs,Cost of Disease,Cost of Sickness,Costs of Disease,Disease Cost,Economic Burden of Disease,Sickness Cost,Burden Of Diseases,Burden, Disease,Cost, Disease,Disease Burdens,Illness Burden,Illness Burdens,Illness Cost,Illness Costs,Sickness Costs

Related Publications

Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
December 2016, Health economics review,
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
December 2016, Health economics review,
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
November 2018, Einstein (Sao Paulo, Brazil),
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
January 2009, The Journal of the Egyptian Public Health Association,
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
October 2011, Arquivos brasileiros de cardiologia,
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
July 1969, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
December 2016, The Journal of the Egyptian Public Health Association,
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
December 2019, BMC health services research,
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
January 2018, Revista iberoamericana de micologia,
Abolhasan Afkar, and Habib Jalilian, and Abolghasem Pourreza, and Habibeh Mir, and Abdolhosein Emami Sigaroudi, and Somayeh Heydari
January 2018, Indian heart journal,
Copied contents to your clipboard!